Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Psychiatry
•
Behavioral Neurology & Neuropsychiatry
•
Public & Community Psychiatry
•
Psychotic Disorders
When do you order brain imaging in young adults presenting with first-episode psychosis in the absence of clear neurologic red flags?
Related Questions
When do you consider using Uzedy, the subcutaneous long-acting injectable version of risperidone?
Which patients do you think would benefit most from xanomeline-tropsium (Cobenfy) monotherapy?
What opportunities do you see for combining xanomeline-tropsium (Cobenfy) with other anti-psychotic agents?
When do you consider the use of lumateperone to treat schizophrenia spectrum disorders?
How do you approach titration or transitioning to Cobenfy in patients currently on an antipsychotic?
How do you approach firearm safety counseling for outpatients with elevated suicide risk who do not meet the criteria for involuntary psychiatric hospitalization?
How do you approach the decision to start clozapine in an inpatient setting when outpatient follow-up resources are limited or the patient’s ability to engage in follow-up is uncertain?
When do you consider using olanzapine/samidorphan?
How have you incorporated long-acting injectables into private practice or other settings that haven’t traditionally offered them?
How would you decide between escalation to clozapine vs xanomeline-tropsium (Cobenfy) for treatment-resistant schizophrenia?
